Sector ratings Daiichi Sankyo Company, Limited

Equities

Market Closed - Japan Exchange Other stock markets 07:30:00 12/05/2026 BST			5-day change	1st Jan Change
2,738.00 ^JPY	+3.36%		+5.31%	-18.22%

05-11	Daiichi Sankyo Company, Limited, 2026 Earnings Call, May 11, 2026
05-11	Daiichi Sankyo's Attributable Profit Falls 12% in Fiscal Year 2025	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
DAIICHI SANKYO COMPANY, LIMITED	30.94B		AAA
ELI LILLY AND COMPANY	862B		A
JOHNSON & JOHNSON	533B		BBB
ABBVIE INC.	358B	-	AA	-	-
ROCHE HOLDING AG	328B		AA
ASTRAZENECA PLC	286B		A
NOVARTIS AG	279B		AAA
MERCK & CO., INC.	275B		A
NOVO NORDISK A/S	210B		A
AMGEN INC.	178B		A
GILEAD SCIENCES, INC.	166B		AA
PFIZER INC.	147B		A
BRISTOL-MYERS SQUIBB COMPANY	114B		A
VERTEX PHARMACEUTICALS INCORPORATED	110B		AA
SANOFI	104B		AA
GSK PLC	100B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	83.36B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	51.94B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	52.3B		AA
BAYER AG	42.93B		AA
Average	215.57B		AA
Weighted average by Cap.			AA